Clinical Trials

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07372079 2026-01-28

Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy

40 enrolled

Breast Neoplasms

NCT05826964 2026-01-13

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

24 enrolled

Breast Neoplasms

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

35 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT06635980 2025-12-12

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

120 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03283384 2025-09-19

NEOLBC

100 enrolled

Breast Neoplasms

NCT07137793 2025-08-22

PTX / BC

46 enrolled

Breast Neoplasms

NCT06678048 2025-06-06

Arsenous Acid for Refractory Triple-Negative Breast Cancer

12 enrolled

Breast Neoplasms

NCT06727357 2024-12-10

Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP

38 enrolled

Breast Neoplasms

NCT03227328 2024-11-07

KENDO

52 enrolled

Breast Neoplasms

NCT02448420 2024-04-18

PATRICIA II

73 enrolled

Breast Neoplasms

NCT06165900 2024-01-03

Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC

136 enrolled

Breast Neoplasms

NCT05569811 2023-09-21

VALENTINE

120 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms

NCT05862610 2023-07-24

The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC

150 enrolled

Breast Neoplasms

NCT02679040 2023-07-03

HIST-RIC

101 enrolled

Breast Neoplasms

NCT03386162 2022-11-28

SAFIR-PI3K

31 enrolled

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT05621434 2022-11-18

A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer

63 enrolled

Breast Neoplasms

NCT02000596 2022-05-27

1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.

2 enrolled 7 charts

Breast Neoplasms

NCT04143282 2021-12-07

Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment

250 enrolled

Breast Neoplasms

NCT04559308 2020-09-22

The Effect of Metformin on Breast Cancer Patients

80 enrolled

Breast Neoplasms

NCT03907098 2019-04-08

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

50 enrolled

Breast Neoplasms

NCT01712009 2018-01-30

NOLAN

600 enrolled 15 charts

Breast Neoplasms

NCT03242551 2017-11-14

BINC-B

120 enrolled

Breast Neoplasms

NCT00584766 2015-05-29

Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer

21 enrolled

Breast Neoplasms

NCT01368263 2015-04-03

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

8 enrolled 5 charts

Breast Neoplasms

NCT01928615 2014-09-29

LISAH

2 enrolled 3 charts

Breast Neoplasms

NCT02115984 2014-07-15

Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer

80 enrolled 7 charts

Breast Neoplasms

NCT00003536 2013-07-10

Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms

NCT00830544 2012-07-13

Neoadjuvant

54 enrolled

Breast Neoplasms

NCT00246571 2012-07-12

Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer

217 enrolled 24 charts

Breast Neoplasms

NCT00135018 2012-05-24

Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer

Breast Neoplasms

NCT00048633 2012-05-23

Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer

30 enrolled

Breast Neoplasms

NCT00851110 2009-02-25

Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors

50 enrolled